BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2004
View Archived Issues
In vitro effects of the novel immunomodulator MDP-C
Read More
Xencor and Genentech collaborate on next-generation therapeutic antibodies
Read More
Isis reports on alicaforsen trial results
Read More
ISA-247 investigated for psoriasis in Canadian phase III study
Read More
Shark tissue extract shown to have antitumor activity in vitro
Read More
Identification of two Candida albicans formins
Read More
Beneficial effects of curcumin may be mediated in part by iron chelation
Read More
Selective, orally active VEGF receptor inhibitor effective against human lung cancer in murine model
Read More
Novel tetrahydroisoquinoline derivatives show insulin-sensitizing effects with fewer side effects
Read More
AnorMED receives FDA response to SPA for AMD-3100 phase III program
Read More
CYT005-AllQbG10 enters phase II house dust mite allergy trial
Read More
Target enrollment reached in phase III study of methylnaltrexone
Read More
FDA requests phase III trials prior to Metvix approval in basal cell carcinoma
Read More
Genta acquires rights to c-myb antisense drug
Read More
SGN-40 enters new phase I trial in NHL
Read More
Single-use vial of Vitrase approved for use as spreading agent
Read More
Oxazolidinone antibacterial agents covered by Ranbaxy patent
Read More
Suntory describes novel agents for the treatment of thrombosis
Read More
Pfizer claims NR2B receptor antagonists for pain, stroke, etc.
Read More
Novel dosage formulations of proton pump antagonists presented by Altana Pharma
Read More
Semafore describes PI-3 kinase inhibitor prodrugs in patent literature
Read More
Two series of calcium channel blockers patented by NeuroMed
Read More
Phase II data on the effects and safety of aselizumab in patients with multiple trauma
Read More
DHEA shows promise in the management of abdominal obesity
Read More
Update on the survival effects of BLP-25 in NSCLC
Read More
New data on the toxicity and pharmacokinetics of XR-11576 in advanced cancer patients
Read More
